Displaying 1 - 2 of 2
The benefits of a Mindfulness-Based Cognitive Therapy (MBCT) group for older people with recurrent and/or chronic depression were explored using a measure of mood (DASS-21) and well-being (Ryff Psychological Well-being Inventory). Thirteen participants started the study and outcome measures were recorded at baseline, post-MBCT group and at a 6-month follow-up. Although there was only a small sample size that had complete pre- and post-group data (n = 9), improvements in depression and anxiety severity were noted and there was a significant improvement on ‘purpose in life’ and marginally significant improvement of ‘personal growth’, two of six domains on a measure of well-being. Participants were satisfied with the structure of the course but were less confident about committing to the daily practice after the group than pre-group. At 6 months follow-up, none of the group had relapsed into a major depressive episode. Further research with larger sample sizes and a control group to control for nonspecific therapeutic group factors is recommended.
The benefits of a Mindfulness-Based Cognitive Therapy (MBCT) group for older people with recurrent and/or chronic depression were explored using a measure of mood (DASS-21) and well-being (Ryff Psychological Well-being Inventory). Thirteen participants started the study and outcome measures were recorded at baseline, post-MBCT group and at a 6-month follow-up. Although there was only a small sample size that had complete pre- and post-group data (n = 9), improvements in depression and anxiety severity were noted and there was a significant improvement on ‘purpose in life’ and marginally significant improvement of ‘personal growth’, two of six domains on a measure of well-being. Participants were satisfied with the structure of the course but were less confident about committing to the daily practice after the group than pre-group. At 6 months follow-up, none of the group had relapsed into a major depressive episode. Further research with larger sample sizes and a control group to control for nonspecific therapeutic group factors is recommended.